Phase I Study of 2- or 3-Week Dosing of Telisotuzumab Vedotin, an Antibody-Drug Conjugate Targeting c-Met, Monotherapy in Patients with Advanced Non-Small Cell Lung Carcinoma
Camidge, D Ross, Morgensztern, Daniel, Heist, Rebecca S, Barve, Minal, Vokes, Everett, Goldman, Jonathan W, Hong, David S, Bauer, Todd M, Strickler, John H, Angevin, Eric, Motwani, Monica, Parikh, Apurvasena, Sun, Zhaowen, Bach, Bruce Allen, Wu, Jun, Komarnitsky, Philip B, Kelly, Karen
Published in Clinical cancer research (01.11.2021)
Published in Clinical cancer research (01.11.2021)
Get full text
Journal Article
Phase 1 dose‐escalation study of single‐agent veliparib in Japanese patients with advanced solid tumors
Nishikawa, Tadaaki, Matsumoto, Koji, Tamura, Kenji, Yoshida, Hiroyuki, Imai, Yuichi, Miyasaka, Aki, Onoe, Takuma, Yamaguchi, Satoshi, Shimizu, Chikako, Yonemori, Kan, Shimoi, Tatsunori, Yunokawa, Mayu, Xiong, Hao, Nuthalapati, Silpa, Hashiba, Hideyuki, Kiriyama, Tsukasa, Leahy, Terri, Komarnitsky, Philip, Fujiwara, Keiichi
Published in Cancer science (01.09.2017)
Published in Cancer science (01.09.2017)
Get full text
Journal Article
Cyclophosphamide and tucotuzumab (huKS-IL2) following first-line chemotherapy in responding patients with extensive-disease small-cell lung cancer
Gladkov, Oleg, Ramlau, Rodryg, Serwatowski, Piotr, Milanowski, Janusz, Tomeczko, Janusz, Komarnitsky, Philip B, Kramer, Daniel, Krzakowski, Maciej J
Published in Anti-cancer drugs (01.11.2015)
Published in Anti-cancer drugs (01.11.2015)
Get more information
Journal Article
A phase 1b study of humanized KS-interleukin-2 (huKS-IL2) immunocytokine with cyclophosphamide in patients with EpCAM-positive advanced solid tumors
Connor, Joseph P, Cristea, Mihaela C, Lewis, Nancy L, Lewis, Lionel D, Komarnitsky, Philip B, Mattiacci, Maria R, Felder, Mildred, Stewart, Sarah, Harter, Josephine, Henslee-Downey, Jean, Kramer, Daniel, Neugebauer, Roland, Stupp, Roger
Published in BMC cancer (15.01.2013)
Published in BMC cancer (15.01.2013)
Get full text
Journal Article
A Phase I Clinical Trial of Darinaparsin in Patients with Refractory Solid Tumors
TSIMBERIDOU, Apostolia Maria, CAMACHO, Luis H, SCHWARTZ, Brian, KURZROCK, Razelle, VERSTOVSEK, Srdan, NG, Chaan, HONG, David S, UEHARA, Cynthia K, GUTIERREZ, Catalina, DARING, Shawn, STEVENS, Jan, KOMARNITSKY, Philip B
Published in Clinical cancer research (15.07.2009)
Published in Clinical cancer research (15.07.2009)
Get full text
Journal Article
Safety, pharmacokinetics, and efficacy of budigalimab with rovalpituzumab tesirine in patients with small cell lung cancer
Calvo, Emiliano, Spira, Alexander, Miguel, María de, Kondo, Shunsuke, Gazzah, Anas, Millward, Michael, Prenen, Hans, Rottey, Sylvie, Warburton, Lydia, Alanko, Tuomo, Cassier, Philippe A., Yoh, Kiyotaka, Italiano, Antoine, Moreno, Victor, Peltola, Katriina, Seto, Takashi, Toyozawa, Ryo, Afar, Daniel E., Englert, Stefan, Komarnitsky, Philip, Lambert, Stacie, Parikh, Apurvasena, Vosganian, Gregory, Gao, Bo
Published in Cancer treatment and research communications (2021)
Published in Cancer treatment and research communications (2021)
Get full text
Journal Article
Efficacy and Safety of Rovalpituzumab Tesirine Compared With Topotecan as Second-Line Therapy in DLL3-High SCLC: Results From the Phase 3 TAHOE Study
Blackhall, Fiona, Jao, Kevin, Greillier, Laurent, Cho, Byoung Chul, Penkov, Konstantin, Reguart, Noemi, Majem, Margarita, Nackaerts, Kristiaan, Syrigos, Konstantinos, Hansen, Karin, Schuette, Wolfgang, Cetnar, Jeremy, Cappuzzo, Federico, Okamoto, Isamu, Erman, Mustafa, Langer, Seppo W., Kato, Terufumi, Groen, Harry, Sun, Zhaowen, Luo, Yan, Tanwani, Poonam, Caffrey, Laura, Komarnitsky, Philip, Reinmuth, Niels
Published in Journal of thoracic oncology (01.09.2021)
Published in Journal of thoracic oncology (01.09.2021)
Get full text
Journal Article
Rovalpituzumab Tesirine as a Maintenance Therapy After First-Line Platinum-Based Chemotherapy in Patients With Extensive-Stage–SCLC: Results From the Phase 3 MERU Study
Johnson, Melissa L., Zvirbule, Zanete, Laktionov, Konstantin, Helland, Aslaug, Cho, Byoung Chul, Gutierrez, Vanesa, Colinet, Benoît, Lena, Herve, Wolf, Martin, Gottfried, Maya, Okamoto, Isamu, van der Leest, Cor, Rich, Patricia, Hung, Jen-Yu, Appenzeller, Christina, Sun, Zhaowen, Maag, David, Luo, Yan, Nickner, Caroline, Vajikova, Alena, Komarnitsky, Philip, Bar, Jair
Published in Journal of thoracic oncology (01.09.2021)
Published in Journal of thoracic oncology (01.09.2021)
Get full text
Journal Article
Phase 1/2, Open-Label, Dose Escalation, Dose Expansion Study of Menin Inhibitor DSP-5336 in Adult Patients (pts) with Acute Leukemia with and without Mixed-Lineage Leukemia (MLL)-Rearrangement or Nucleophosmin 1 (NPM1) Mutation
Daver, Naval, Affinito, John, Cai, Hongliang, Dobrowolska, Hanna, Dow, Edward, Eguchi, Ken, Song, Gregory, Stoudemire, Jay, Watanbe, Akinobu, Komarnitsky, Philip
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Phase 1/2, open-label, dose-escalation, dose-expansion study of menin inhibitor DSP-5336 in adult patients with acute leukemia with and without mixed-lineage leukemia ( MLL )-rearrangement (r) or nucleophosmin 1 ( NPM1 ) mutation (m)
Daver, Naval Guastad, Affinito, John, Cai, Hongliang, Dobrowolska, Hanna, Eguchi, Ken, Zhang, Zijing, Stoudemire, Jay, Watanabe, Akinobu, Martinez, Pablo, Komarnitsky, Philip
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
P38-8 Phase 1/2 study of menin inhibitor DSP-5336 in acute leukemia with and without MLL rearrangement or NPM1 mutation
Daver, Naval, Ikezoe, Takayuki, Watts, Justin, Hosono, Naoko, Ogawa, Yoshiaki, Miyazaki, Yasushi, Erba, Harry, Affinito, John, Cai, Hongliang, Brooks, Emily, Eguchi, Ken, Stoudemire, Jay, Watanabe, Akinobu, Kuwaki, Takahiro, Hitron, Matthew, Komarnitsky, Philip, Yuda, Junichiro
Published in Annals of oncology (01.11.2023)
Published in Annals of oncology (01.11.2023)
Get full text
Journal Article
Predictors associated with development of pleural and pericardial effusions in patients with small cell lung cancer treated with third-line therapy
Jiang, Rui, Koch, Martina, Gulbranson, Scott, Komarnitsky, Philip B., Papademetriou, Eros, Tyczynski, Jerzy Edward
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Phase 1/2, Open-Label, Dose Escalation, Dose Expansion Study of Menin Inhibitor DSP-5336 in Adult Patients with Acute Leukemia with and without Mixed-Lineage Leukemia (MLL)-Rearrangement (R) or Nucleophosmin 1 (NPM1) Mutation (m)
Daver, Naval, Ikezoe, Takayuki, Watts, Justin, Hosono, Naoko, Ogawa, Yoshiaki, Miyazaki, Yasushi, Erba, Harry P., Affinito, John, Brooks, Emily, Eguchi, Ken, Cai, Hongliang, Xu, Bo, Stoudemire, Jay, Hitron, Matthew, Watanabe, Akinobu, Komarnitsky, Philip, Yuda, Junichiro
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
A Phase 1 Study Evaluating Rovalpituzumab Tesirine in Frontline Treatment of Patients With Extensive-Stage SCLC
Hann, Christine L., Burns, Timothy F., Dowlati, Afshin, Morgensztern, Daniel, Ward, Patrick J., Koch, Martina M., Chen, Chris, Ludwig, Carrianne, Patel, Maulik, Nimeiri, Halla, Komarnitsky, Philip, Camidge, D. Ross
Published in Journal of thoracic oncology (01.09.2021)
Published in Journal of thoracic oncology (01.09.2021)
Get full text
Journal Article
A Phase I Dose-Escalation Study of Veliparib Combined with Carboplatin and Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer and Other Solid Tumors
Atrafi, Florence, Groen, Harry J M, Byers, Lauren A, Garralda, Elena, Lolkema, Martijn P, Sangha, Randeep S, Viteri, Santiago, Chae, Young Kwang, Camidge, D Ross, Gabrail, Nashat Y, Hu, Beibei, Tian, Tian, Nuthalapati, Silpa, Hoening, Elizabeth, He, Lei, Komarnitsky, Philip, Calles, Antonio
Published in Clinical cancer research (15.01.2019)
Published in Clinical cancer research (15.01.2019)
Get full text
Journal Article
Abstract 4228: Incidence of pericardial and pleural effusions in patients with small cell lung cancer treated with third-line or later-line therapy: An analysis of electronic health records data
Jiang, Rui, Gulbranson, Scott H., Bhattacharya, Mondira, Lievano, Fabio A., Komarnitsky, Philip, Koch, Martina M., Potluri, Ravi, Tyczynski, Jerzy E.
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Get full text
Journal Article
Abstract 1213: Comorbidities and concomitant medication use in small cell lung cancer patients treated with third and later-lines of therapy: An analysis of electronic health records data
Jiang, Rui, Gulbranson, Scott H., Komarnitsky, Philip, Lievano, Fabio A., Koch, Martina M., Papademetriou, Eros, Tyczynski, Jerzy E.
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Get full text
Journal Article
Abstract 4227: Treatment regimens, treatment duration, and between-treatment duration in patients with small cell lung cancer across lines of therapy: An analysis of electronic health records data
Jiang, Rui, Gulbranson, Scott H., Komarnitsky, Philip, Koch, Martina M., Lievano, Fabio A., Potluri, Ravi, Scripture, Charity, Tyczynski, Jerzy E.
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Get full text
Journal Article